New OTC Nexium approved

Share this article:

Pfizer's consumer portfolio now includes a 24-hour version of over-the-counter Nexium. The company announced Friday that the FDA greenlighted the no-prescription heartburn medication.

The company is also pursuing an OTC version of its former prescription blockbuster cholesterol medication Lipitor.

Pfizer acquired worldwide marketing rights to the non-Rx version of AZ's blockbuster proton-pump inhibitor in 2012. Deal terms called for a $250-million upfront payment.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.